ironwood pharmaceuticals inc
Christopher T. Walsh M.D., Ph.D.
Scientific Advisor, Director, Member of Pharmaceuticals Advisory Committee and Member of Governance & Nominating Committee, Ironwood Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 112 board members in 8 different organizations across 12 different industries.|
See Board Relationships
Mr. Christopher T. Walsh, also known as Chris MD, PhD., serves as Scientific advisor of Ironwood Pharmaceuticals, Inc. Mr. Walsh serves as an Advisor of LS9, Inc. He has been Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology of Harvard Medical School since June 1987. He is a Co-Founder of Magen BioSciences, Inc. He served as President of the Dana-Farber Cancer Institute from 1992 to 1995. He is an expert in enzyme stereochemistry and reaction ...
301 Binney StreetPhone: 617-621-7722
Cambridge, Massachusetts 02142
Board Members Memberships*
Corporate Secretary and Director
Co-Founder, Director and Member of Scientific Advisory Board
Director, Chairman of Corporate Governance & Nominating Committee, Member of Compensation Committee and Member of Strategic Advisory Committee
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating Committee
Scientific Advisor, Director, Member of Pharmaceuticals Advisory Committee and Member of Governance & Nominating Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Rick E. Winningham||Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee|
|Howard W. Robin||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee|
Progenics Pharmaceuticals, Inc.
|Ryuji Ueno M.D., Ph.D., Ph.D.||Co-Founder, Chairman, Chief Executive Officer, Chief Scientific Officer and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Richard Martin Steeves BSc., Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|778.0K GBP||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26